| Product NDC: | 55289-330 | 
| Proprietary Name: | PredniSONE | 
| Non Proprietary Name: | PredniSONE | 
| Active Ingredient(s): | 10 mg/1 & nbsp; PredniSONE | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 55289-330 | 
| Labeler Name: | PD-Rx Pharmaceuticals, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA084122 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20030213 | 
| Package NDC: | 55289-330-10 | 
| Package Description: | 10 BOTTLE, PLASTIC in 1 BOTTLE, PLASTIC (55289-330-10) > 7 TABLET in 1 BOTTLE, PLASTIC (55289-330-07) | 
| NDC Code | 55289-330-10 | 
| Proprietary Name | PredniSONE | 
| Package Description | 10 BOTTLE, PLASTIC in 1 BOTTLE, PLASTIC (55289-330-10) > 7 TABLET in 1 BOTTLE, PLASTIC (55289-330-07) | 
| Product NDC | 55289-330 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | PredniSONE | 
| Dosage Form Name | TABLET | 
| Route Name | ORAL | 
| Start Marketing Date | 20030213 | 
| Marketing Category Name | ANDA | 
| Labeler Name | PD-Rx Pharmaceuticals, Inc. | 
| Substance Name | PREDNISONE | 
| Strength Number | 10 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes |